Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_assertion type Assertion NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_head.
- NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_assertion description "[For molecular imaging strategies, a putative panel consisting of markers for EGFR, IGF1-R, FGFR2, GLUT1, CAXII, CD44v6 was positive in 77% of cases and might be considered for development of molecular tracers for male breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_provenance.
- NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_assertion evidence source_evidence_literature NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_provenance.
- NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_assertion SIO_000772 23308200 NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_provenance.
- NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_assertion wasDerivedFrom befree-20150227 NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_provenance.
- NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_assertion wasGeneratedBy ECO_0000203 NP276898.RAW9-z0mgB85Vqa30yYlMd88ZbA2OCog1UFJcmRm1b4y8130_provenance.